NQO1 Antibodies

Santa Cruz Biotechnology provides a broad selection of NQO1 monoclonal antibodies for research focused on NAD(P)H:quinone oxidoreductase 1. Multiple applications are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NQO1 is a crucial enzyme involved in the detoxification of quinones and the protection of cells from oxidative stress. The enzyme plays a significant role in cellular defense mechanisms and is implicated in various diseases, including cancer and neurodegenerative disorders. Understanding NQO1 function is essential for developing therapeutic strategies aimed at enhancing cellular resilience against oxidative damage. Research into NQO1 continues to reveal new insights about its role in maintaining cellular health and preventing disease progression. Investigating NQO1 expression patterns helps scientists better understand its involvement in various biological pathways and disease states. Advanced research techniques using NQO1 monoclonal antibodies enable precise detection and quantification in diverse experimental settings. Santa Cruz Biotechnology monoclonal antibodies for NQO1 support researchers worldwide in advancing scientific understanding of cellular defense mechanisms and disease pathways.